First-in-class, first-in-human phase I results of targeted agents: Highlights of the 2008 American Society of Clinical Oncology meeting

<p>Abstract</p> <p>This review summarizes phase I trial results of 11 drugs presented at the American Society of Clinical Oncology meeting held in Chicago IL from May 30 to June 3rd 2008: BMS-663513, CT-322, CVX-045, GDC-0449, GRN163L, LY2181308, PF-00562271, RAV12, RTA 402, XL765,...

Full description

Bibliographic Details
Main Authors: Siu Lillian L, Molckovsky Andrea
Format: Article
Language:English
Published: BMC 2008-10-01
Series:Journal of Hematology & Oncology
Online Access:http://www.jhoonline.org/content/1/1/20